If patients have a current sick day plan, they should follow this. Otherwise:
Remember increased blood glucose testing, blood ketone testing, increase in insulin doses and rehydration may be necessary.
If patients are in respiratory distress, at risk of hypoxia, or have vomiting or diarrhoea their Metformin and Jardiance must be stopped at this time.
For patients taking Jardiance, there is increased risk of euglycaemic diabetic ketoacidosis (euDKA) if they develop diarrhoea or vomiting. Anyone prescribed Jardiance who presents acutely unwell to the practice should have their capillary ketone levels checked using the Caresens Dual meter (meter and strips available on MPSO) even if their blood glucose levels are within target range. Ketones ranging 0.6 – 1.5mmol/L may require fluid replacement and correction insulin (Novorapid/Humalog/Apidra) prn, but for those above 1.5mmol/L transfer to hospital may be required.
Patients prescribed Jardiance should be discouraged from following a ketogenic diet strategy as this increases the likelihood of euDKA.
During bouts of illness the blood glucose is likely to be high due to stress, or low due to vomiting or low food intake. It is important patients increase blood glucose monitoring and are helped to make changes to insulin doses in reaction to current blood glucose levels. A correction insulin regimen at mealtimes may be required. Further information can be found on the Ministry of Health website.
Remember people with T2 or undiagnosed T2 can present with hyperosmolar hyperglycaemic state (HHS) and admission to hospital may be necessary in these cases.
Sick day advice resources are below in the files and links section.
Kathy joined Pinnacle earlier this month as clinical diabetes specialist for Waikato, replacing the role previously held by Anne Waterman.
Read morePharmac is now allowing new special authority applications for liraglutide (Victoza) from 1 March 2025. The special authority criteria will be the same as when special authorities were suspended in May 2024. This will again allow prescribing according to national guidelines and best practice. Pharmac has assured the intention is for no further suspensions of special authority criteria for GLP-1 agonists to allow ongoing access for those who meet criteria. To ensure availability, it continues to be important these medications are only prescribed for people with type 2 diabetes mellitus (T2DM). Please contact the Pinnacle diabetes lead in your area if you have any questions.
Read moreThe clinical diabetes specialist in primary care provides clinical mentorship and advice to the practice team in supporting patients with diabetes.
View detailsA guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.